易方达标普生物科技美元现汇A(003720)
动态评分： 4.62分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2020-12-31 | BPMC | Blueprint Medicines Corp | 74.57 | 0.83% |
| 2020-12-31 | KPTI | Karyopharm Therapeutics Inc | 74.69 | 0.83% |
| 2020-12-31 | FATE | Fate Therapeutics Inc | 73.21 | 0.82% |
| 2020-12-31 | GILD | 吉利德科学 | 73.18 | 0.82% |
| 2020-12-31 | ALLK | Allakos Inc | 72.07 | 0.81% |
| 2020-12-31 | BEAM | Beam Therapeutics Inc | 72.34 | 0.81% |
| 2020-12-31 | RARE | Ultragenyx Pharmaceutical Inc | 72.89 | 0.81% |
| 2020-12-31 | ALKS | 阿尔凯默斯 | 71.49 | 0.8% |
| 2020-12-31 | PTCT | PTC Therapeutics Inc | 71.68 | 0.8% |
| 2020-12-31 | ALLO | Allogene Therapeutics Inc | 70.26 | 0.79% |
| 2020-12-31 | IOVA | Iovance Biotherapeutics Inc | 70.91 | 0.79% |
| 2020-12-31 | MRTX | Mirati Therapeutics Inc | 70.22 | 0.78% |
| 2020-12-31 | SGEN | Seagen Inc | 69.82 | 0.78% |
| 2020-12-31 | BCRX | BioCryst Pharmaceuticals Inc | 68.54 | 0.77% |
| 2020-12-31 | FGEN | FibroGen Inc | 69.02 | 0.77% |
| 2020-12-31 | CYTK | Cytokinetics Inc | 67.59 | 0.76% |
| 2020-12-31 | MRSN | 梅莎娜制药 | 67.71 | 0.76% |
| 2020-12-31 | NVAX | 诺瓦瓦克斯医药 | 68.1 | 0.76% |
| 2020-12-31 | OPK | OPKO健康 | 67.76 | 0.76% |
| 2020-12-31 | AKBA | Akebia Therapeutics Inc | 67.42 | 0.75% |
公告&资料
